255 results Stibbe advises Dutch pension funds Advising several Dutch pension funds in connection with enforcement action taken by the Dutch Central Bank in view of actual or threatened failure to satisfy capital adequacy requirements. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Reporting for non-EU AIFMs as of Q1 2023 Effective from Q1 2023, the Netherlands Authority for the Financial Markets (the “AFM”) indicated that it will require AIFMs who have notified AIFs for marketing under Article 36/Article 42 AIFMD to submit Periodic Reports. DNB's AI Guidance: balancing innovation with prudence The Dutch Central Bank (De Nederlandsche Bank, DNB) has shared new key considerations on the use of artificial intelligence in the insurance sector. E-book: 'Sustainable Finance in Europe' Stibbe lawyers Marieke Driessen, Loes van Dijk and Ingrid van der Klooster contributed to the book 'Sustainable Finance in Europe' which was recently published. Tom Barkhuysen Partner Amsterdam Tom Barkhuysen Partner Amsterdam The third AFM report on SFDR compliance signals tightening enforcement and highlights a shift in supervision towards the quality of disclosures A recent report of the AFM underlines its focus on monitoring SFDR compliance, signals tightening enforcement action against those lagging behind, and highlights a new phase of supervisory attention for clear, accurate and reliable SFDR disclosures. Top tips for doing capital markets deals in the Netherlands Nora Offergelt and Pieter Schütte have written a Practice Note with Practical Law Capital Markets in which they discuss the top tips for doing capital markets deals in the Netherlands. Consultatievoorstel voor Wijzigingswet toezicht financiële markten 2024 Ingrid van der Klooster bespreekt de hoofdlijnen van de voorgestelde wijzigingen in het consultatievoorstel dat op 29 april 2022 gepubliceerd is. On the Board room agenda: ESG & sustainability risks and opportunities throughout the supply chain When handled properly, ESG and sustainability create opportunities for companies in the real estate sector to make their business model future proof and to benefit the bottom line. ESG has thus become an important driver for business considerations. Greenwashing in the EU financial markets: sustainable finance status update The European financial markets feature numerous financial products with characteristics such as ‘green’, ‘ESG’, ‘sustainable’, ‘climate’, ‘transition’, ‘impact’ or similar. But when is it fair to name or label financial products as such? Transition Finance Transition finance provides options for borrowers and issuers who are not able or willing to commit to green and sustainability principles in their financing options, as they are transitioning their businesses onto the path towards a sustainable future. Pagination Previous page Page 12 Current page 13 Page 14 Page 15 Next page
Stibbe advises Dutch pension funds Advising several Dutch pension funds in connection with enforcement action taken by the Dutch Central Bank in view of actual or threatened failure to satisfy capital adequacy requirements.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
Reporting for non-EU AIFMs as of Q1 2023 Effective from Q1 2023, the Netherlands Authority for the Financial Markets (the “AFM”) indicated that it will require AIFMs who have notified AIFs for marketing under Article 36/Article 42 AIFMD to submit Periodic Reports.
DNB's AI Guidance: balancing innovation with prudence The Dutch Central Bank (De Nederlandsche Bank, DNB) has shared new key considerations on the use of artificial intelligence in the insurance sector.
E-book: 'Sustainable Finance in Europe' Stibbe lawyers Marieke Driessen, Loes van Dijk and Ingrid van der Klooster contributed to the book 'Sustainable Finance in Europe' which was recently published.
The third AFM report on SFDR compliance signals tightening enforcement and highlights a shift in supervision towards the quality of disclosures A recent report of the AFM underlines its focus on monitoring SFDR compliance, signals tightening enforcement action against those lagging behind, and highlights a new phase of supervisory attention for clear, accurate and reliable SFDR disclosures.
Top tips for doing capital markets deals in the Netherlands Nora Offergelt and Pieter Schütte have written a Practice Note with Practical Law Capital Markets in which they discuss the top tips for doing capital markets deals in the Netherlands.
Consultatievoorstel voor Wijzigingswet toezicht financiële markten 2024 Ingrid van der Klooster bespreekt de hoofdlijnen van de voorgestelde wijzigingen in het consultatievoorstel dat op 29 april 2022 gepubliceerd is.
On the Board room agenda: ESG & sustainability risks and opportunities throughout the supply chain When handled properly, ESG and sustainability create opportunities for companies in the real estate sector to make their business model future proof and to benefit the bottom line. ESG has thus become an important driver for business considerations.
Greenwashing in the EU financial markets: sustainable finance status update The European financial markets feature numerous financial products with characteristics such as ‘green’, ‘ESG’, ‘sustainable’, ‘climate’, ‘transition’, ‘impact’ or similar. But when is it fair to name or label financial products as such?
Transition Finance Transition finance provides options for borrowers and issuers who are not able or willing to commit to green and sustainability principles in their financing options, as they are transitioning their businesses onto the path towards a sustainable future.